Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 75

Improving physical activity for individuals with spinal cord injury using smartphones

Official title: mHealth-based Just-In-Time Adaptive Intervention to Improve Physical Activity Levels of Individuals With Spinal Cord Injury

Run by Temple University · NCT05317832 · Data updated 2026-11-12

This study is testing if using a smartphone app that gives personalized feedback can help people with spinal cord injuries be more active compared to a regular online program.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment196 (estimated)
SponsorTemple University
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedMay 25, 2023
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedJune 24, 2026
Trial IDNCT05317832 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18-75 with a spinal cord injury classified at cervical level 5 and below, who primarily use a wheelchair and are ready to engage in physical activity.

Probably not a fit

Patients with secondary complications that restrict their activity or those diagnosed with traumatic brain injury may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research evaluates a sensor-enabled, just-in-time adaptive intervention (JITAI) strategy aimed at increasing and sustaining physical activity levels among individuals with spinal cord injuries (SCI). Participants will be randomized into two groups: one receiving a standard web-based physical activity intervention and the other receiving the same intervention combined with JITAI, which provides tailored feedback based on real-time physical activity data. The study will also utilize a micro-randomized trial design to optimize the delivery of feedback and recommendations, while investigating various moderators that may affect outcomes. The goal is to determine if the integration of JITAI leads to significantly higher physical activity levels compared to the standard intervention alone.

Why it matters

Potential benefit: If successful, this approach could significantly enhance physical activity levels and overall quality of life for individuals with spinal cord injuries.

How similar studies have gone: Other studies have shown promise with similar just-in-time adaptive interventions, suggesting potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Participants with SCI will be included if they are:

* 18-75 years of age
* have a traumatic or non-traumatic SCI (classification of neurological level of injury at cervical level 5 (C5) and below)
* are at least 6-months post-SCI
* use a manual or a power wheelchair as their primary means of mobility (\>80% of time)
* can use their arms to exercise
* show readiness to physical activity as assessed by the Physical Activity Readiness Questionnaire
* have experience using a smartphone and smartwatch.

Exclusion Criteria: Participants will be excluded if they have:

* any secondary complications that medically restrict their activity in any way such as cardiovascular disease, pressure injuries, contractures, and infections
* are diagnosed with traumatic brain injury.

Where it's running

  • Temple University
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.